These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15196872)

  • 1. The protooncogene c-KIT is expressed in leiomyosarcomas of the uterus.
    Raspollini MR; Paglierani M; Taddei GL; Villanucci A; Amunni G; Taddei A
    Gynecol Oncol; 2004 Jun; 93(3):718. PubMed ID: 15196872
    [No Abstract]   [Full Text] [Related]  

  • 2. Uterine leiomyosarcomas express KIT protein but lack mutation(s) in exon 9 of c-KIT.
    Raspollini MR; Pinzani P; Simi L; Amunni G; Villanucci A; Paglierani M; Taddei GL
    Gynecol Oncol; 2005 Aug; 98(2):334-5. PubMed ID: 16039311
    [No Abstract]   [Full Text] [Related]  

  • 3. c-Kit expression in patients with uterine leiomyosarcomas: a potential alternative therapeutic treatment.
    Raspollini MR; Amunni G; Villanucci A; Pinzani P; Simi L; Paglierani M; Taddei GL
    Clin Cancer Res; 2004 May; 10(10):3500-3. PubMed ID: 15161707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus.
    Wang L; Felix JC; Lee JL; Tan PY; Tourgeman DE; O'Meara AT; Amezcua CA
    Gynecol Oncol; 2003 Aug; 90(2):402-6. PubMed ID: 12893208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological analysis of c-kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpus.
    Winter WE; Seidman JD; Krivak TC; Chauhan S; Carlson JW; Rose GS; Birrer MJ
    Gynecol Oncol; 2003 Oct; 91(1):3-8. PubMed ID: 14529656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imatinib is not a potential alternative treatment for uterine leiomyosarcoma.
    Serrano C; Mackintosh C; Herrero D; Martins AS; de Alava E; Hernández T; Pérez-Fontán J; Abad M; Pérez A; Serrano E; Bullón A; Orfao A
    Clin Cancer Res; 2005 Jul; 11(13):4977-9; author reply 4979-80. PubMed ID: 16000598
    [No Abstract]   [Full Text] [Related]  

  • 7. C-kit expression in uterine leiomyosarcomas: an immunocytochemical study of 29 cases of malignant smooth muscle tumors of the uterus.
    Raspollini MR; Villanucci A; Amunni G; Paglierani M; Taddei A; Taddei GL
    J Chemother; 2003 Feb; 15(1):81-4. PubMed ID: 12678420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT.
    Rushing RS; Shajahan S; Chendil D; Wilder JL; Pulliam J; Lee EY; Ueland FR; van Nagell JR; Ahmed MM; Lele SM
    Gynecol Oncol; 2003 Oct; 91(1):9-14. PubMed ID: 14529657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DOG1 immunoreactivity in uterine leiomyosarcomas.
    Sah SP; McCluggage WG
    J Clin Pathol; 2013 Jan; 66(1):40-3. PubMed ID: 23038686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-kit protein expression in uterine and ovarian mesenchymal tumours.
    Erdogan G; Bassorgun CI; Pestereli HE; Simsek T; Karaveli S
    APMIS; 2007 Mar; 115(3):204-9. PubMed ID: 17367465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of bcl-2 and bax protein in uterine leiomyosarcomas and leiomyomas].
    Zhang ZL; Zhang Y; Zhou JH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 30(2):183-6. PubMed ID: 15898430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of expression of c-kit protein (CD117) in mesenchymal tumors of the uterus and ovary.
    Klein WM; Kurman RJ
    Int J Gynecol Pathol; 2003 Apr; 22(2):181-4. PubMed ID: 12649674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMB-45 reactivity in conventional uterine leiomyosarcomas.
    Simpson KW; Albores-Saavedra J
    Am J Surg Pathol; 2007 Jan; 31(1):95-8. PubMed ID: 17197924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine epithelioid leiomyosarcoma with c-kit expression and YWHAE gene rearrangement: a case report of a diagnostic pitfall of uterine sarcoma.
    Kubo T; Sugita S; Wada R; Kikuchi N; Iwasaki M; Ito Y; Sugawara T; Fujita H; Emori M; Tanaka R; Hirano H; Saito T; Hasegawa T
    Diagn Pathol; 2017 Mar; 12(1):26. PubMed ID: 28288693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies?
    Raspollini MR; Susini T; Amunni G; Paglierani M; Taddei A; Marchionni M; Scarselli G; Taddei GL
    Gynecol Oncol; 2005 Jan; 96(1):159-67. PubMed ID: 15589595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma.
    Leiser AL; Anderson SE; Nonaka D; Chuai S; Olshen AB; Chi DS; Soslow RA
    Gynecol Oncol; 2006 Apr; 101(1):86-91. PubMed ID: 16289259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of leiomyosarcoma of the uterus in MMTV-CR-1 transgenic mice.
    Strizzi L; Bianco C; Hirota M; Watanabe K; Mancino M; Hamada S; Raafat A; Lawson S; Ebert AD; D'Antonio A; Losito S; Normanno N; Salomon DS
    J Pathol; 2007 Jan; 211(1):36-44. PubMed ID: 17072826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelioid leiomyosarcoma of the uterus containing sex cord-like elements.
    Lee FY; Wen MC; Wang J
    Int J Gynecol Pathol; 2010 Jan; 29(1):67-8. PubMed ID: 19952934
    [No Abstract]   [Full Text] [Related]  

  • 19. Mesenchymal tumors of the uterus. IV. Diagnosis and prognosis of leiomyosarcomas.
    Taylor HB; Norris HJ
    Arch Pathol; 1966 Jul; 82(1):40-4. PubMed ID: 5938448
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of c-kit protooncogene in human hepatocellular carcinoma.
    Chung CY; Yeh KT; Hsu NC; Chang JH; Lin JT; Horng HC; Chang CS
    Cancer Lett; 2005 Jan; 217(2):231-6. PubMed ID: 15617841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.